Product Name |
Clindamycin D3 |
Alternate Names |
Clindamycin Stable Isotopes, Stable Isotopes of Clindamycin |
CAT No. |
CS-O-35224
|
CAS No. |
18323-44-9 (Unlabeled) |
Category |
Stable Isotopes |
Stock |
IN-Stock
|
Mol. Wt. |
428 g/mol |
Mol. For. |
C18H30D3ClN2O5S
|
Hazardous |
This is not a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
Clindamycin |
Canonical Smiles |
CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl |
InchIKey |
KDLRVYVGXIQJDK-AWPVFWJPSA-N |
Inchl |
InChI=1S/C18H33ClN2O5S/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25)/t9-,10+,11-,12+,13-,14+,15+,16+,18+/m0/s1 |
IUPAC |
(2S,4R)-N-[(1S,2S)-2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
Clindamycin D3 is a deuterated form of Clindamycin, which is a broad-spectrum antibiotic that belongs to the class of lincosamide antibiotics. It is commonly used to treat a wide range of bacterial infections in the body, including skin and soft tissue infections, respiratory infections, bone and joint infections, and dental infections. The deuterium substitution in Clindamycin D3 does not affect its antibacterial activity, but it does increase its stability and bioavailability.
The chemical formula of Clindamycin D3 is C18H33D3N2O5S, and its molecular weight is 424.64 g/mol. The deuterium substitution is located at the C-2 position of the propyl side chain of Clindamycin. The mechanism of action of Clindamycin D3 involves the inhibition of bacterial protein synthesis by binding to the 50S ribosomal subunit, thereby preventing the elongation of protein chains.
Clindamycin D3 is available in various forms, including oral capsules, oral solution, and injectable solution. The dosage and duration of treatment depend on the type and severity of the infection and the patient's age and medical condition. It is important to follow the prescribed dosage and complete the full course of treatment to ensure the effectiveness of the antibiotic and prevent the development of antibiotic resistance.
In conclusion, Clindamycin D3 is a useful antibiotic that can effectively treat a wide range of bacterial infections. Its deuterium substitution increases its stability and bioavailability without affecting its antibacterial activity. Proper usage and adherence to the prescribed dosage and duration of treatment are crucial for the successful treatment of bacterial infections.